Hendry J H
Adlington, Macclesfield, UK.
Ann ICRP. 2012 Oct-Dec;41(3-4):64-71. doi: 10.1016/j.icrp.2012.06.013. Epub 2012 Aug 22.
For protection purposes, the biological effects of radiation are separated into stochastic effects (cancer, hereditary effects) presumed to be unicellular in origin, and tissue reactions due to injury in populations of cells. The latter are deterministic effects, renamed 'tissue reactions' in the 2007 Recommendations of the International Commission on Radiological Protection because of the increasing evidence of the ability to modify responses after irradiation. Tissue reactions become manifest either early or late after doses above a threshold dose, which is the basis for recommended dose limits for avoiding such effects. Latency time before manifestation is related to cell turnover rates, and tissue proliferative and structural organisation. Threshold doses have been defined for practical purposes at 1% incidence of an effect. In general, threshold doses are lower for longer follow-up times because of the slow progression of injury before manifestation. Radiosensitive individuals in the population may contribute to low threshold doses, and in the future, threshold doses may be increased by the use of various biological response modifiers post irradiation for reducing injury. Threshold doses would be expected to be higher for fractionated or protracted doses, unless doses below the threshold dose only cause single-hit-type events that are not modified by repair/recovery phenomena, or if different mechanisms of injury are involved at low and high doses.
出于防护目的,辐射的生物学效应被分为随机性效应(癌症、遗传效应),这类效应被认为起源于单细胞,以及细胞群体损伤导致的组织反应。后者为确定性效应,在国际放射防护委员会2007年的建议中被重新命名为“组织反应”,因为越来越多的证据表明照射后反应具有可调节性。在高于阈剂量的情况下,组织反应会在早期或晚期显现出来,这是推荐用于避免此类效应的剂量限值的依据。显现前的潜伏期与细胞更新率、组织增殖和结构组织有关。出于实际目的,阈剂量被定义为效应发生率为1%时的剂量。一般来说,由于显现前损伤进展缓慢,随访时间越长阈剂量越低。人群中的辐射敏感个体可能导致阈剂量较低,并且在未来,照射后使用各种生物反应调节剂来减轻损伤可能会提高阈剂量。分次或延长剂量的阈剂量预计会更高,除非低于阈剂量的剂量仅引起不会因修复/恢复现象而改变的单次打击型事件,或者在低剂量和高剂量下涉及不同的损伤机制。